We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Balloon Catheters in Cases of Abnormal Placentation (Accreta)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01373255
First Posted: June 14, 2011
Last Update Posted: June 16, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Raed Salim, HaEmek Medical Center, Israel
  Purpose
Placenta accreta is a relatively rare event, in which the placenta is abnormally implanted into the uterine myometrium. The most significant complication is intense bleeding, mainly during labor. The most important risk factors are previous cesarean delivery, placenta previa, and advanced maternal age. Cesarean hysterectomy is the recommended management. During the recent years, inserting intravascular balloon catheter for occlusion and/or arterial embolization, was introduced as an adjuvant therapy in order to minimize blood loss during cesarean hysterectomy or in conduct with conservative management with the intent of avoiding hysterectomy in selective cases. Contradicting reports exist regarding the effectiveness and safety of the catheters in cases of placenta accreta. The objective of this study is to estimate the efficacy of the balloon catheters among women diagnosed with a placenta accreta.

Condition Intervention
Post Partum Bleeding Procedure: internal iliac catheterization

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Balloon Catheter for Occlusion of the Pelvic Vasculature as an Adjuvant Therapy in Cases of Placenta Accreta

Resource links provided by NLM:


Further study details as provided by Raed Salim, HaEmek Medical Center, Israel:

Primary Outcome Measures:
  • Number of blood products transfused [ Time Frame: 5 years ]

Secondary Outcome Measures:
  • Need for hysterectomy [ Time Frame: 5 years ]
  • catheter`s side effects [ Time Frame: 5 years ]
  • Length of hospitalization [ Time Frame: 5 years ]

Enrollment: 24
Study Start Date: January 2009
Study Completion Date: April 2015
Primary Completion Date: April 2015 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: internal iliac catheterization
Women in this arm will undergo internal iliac artery catheterization prior to the cesarean delivery
Procedure: internal iliac catheterization
Women in this arm will undergo internal iliac artery catheterization prior to the cesarean delivery
Other Name: internal iliac artery catheterization
No Intervention: No intervention
no intervention prior to cesarean

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 45 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • pregnant women age 18-45
  • antepartum diagnosis of placenta accreta

Exclusion Criteria:

- women who refuse to participate

  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01373255


Locations
Israel
Haemek Medical Center
Afula, Israel
Sponsors and Collaborators
HaEmek Medical Center, Israel
Investigators
Principal Investigator: Raed Salim Dep. OB/GYN, HaEmek Medical Center, Afula, Israel
  More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Raed Salim, MD, HaEmek Medical Center, Israel
ClinicalTrials.gov Identifier: NCT01373255     History of Changes
Other Study ID Numbers: 0043-08-EMC
Acreta02 ( Other Identifier: Emek Medical Center )
First Submitted: June 10, 2011
First Posted: June 14, 2011
Last Update Posted: June 16, 2015
Last Verified: June 2015

Keywords provided by Raed Salim, HaEmek Medical Center, Israel:
Placenta accreta
Internal iliac artery catheterization
Post partum bleeding

Additional relevant MeSH terms:
Hemorrhage
Placenta Accreta
Postpartum Hemorrhage
Pathologic Processes
Obstetric Labor Complications
Pregnancy Complications
Placenta Diseases
Puerperal Disorders
Uterine Hemorrhage